More internal PubMed Central emails show quite clearly that PMC is wasting taxpayers’ money solving problems publishers have already solved. Continue reading
Articles are published before they’re reviewed; doubts about a paper are viewed as a positive status; papers only need to contain “science;” review and revision can continue forever; and PubMed Central is their certifying entity. Welcome to the world of F1000 Research. Continue reading
How a publisher study of institutional repositories is used against those who created it. Continue reading
PubMed Central reduces article downloads from 14 biomedical society websites when articles are made freely available after embargo. Continue reading
The continued silence from major funders involved in the eLife-PubMed Central scandal is creating a noise all its own. Continue reading
The OSTP memorandum is a reasonable step forward for everyone. However, a NYT editorial provides misleading interpretations of its scope and design. Continue reading
The National Library of Medicine has a couple of powerful brands, but they’ve become conflated and compromised by poor brand management. Ultimately, their brand value is derived from the value of the MEDLINE brand, which may now be spread too thin. Continue reading
Attacks — both overt and covert — from OA advocates and NIH/NLM phantoms come in the wake of the posts revealing how eLife and PubMed Central coordinated activities and kept secrets. Continue reading
Conflicts of interest at PubMed Central have been mismanaged, and seem to have led to loading the National Advisory Committee with Wellcome representatives, among other things. Continue reading
When PubMed Central expedited eLife, PeerJ wondered why. Emails within PMC suggest they were tempted to help PeerJ in the same way. They even talked with eLife about how to handle things. Continue reading